Nabiha Saklayen, Ph.D., CEO and Co-Founder
Cambridge, MA
Cellino is the first cell and tissue foundry to offer single cell precision for regenerative medicine. Cellino’s platform technology combines laser optics, machine learning, and stem cell biology to automate the iPSC reprogramming and differentiation processes, resulting in highly-functional iPSC-derived cells and tissues.

By using this website you agree to accept our Privacy Policy and Terms & Conditions